156 related articles for article (PubMed ID: 2128807)
1. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders.
Horny HP; Ruck M; Wehrmann M; Kaiserling E
Br J Haematol; 1990 Oct; 76(2):186-93. PubMed ID: 2128807
[TBL] [Abstract][Full Text] [Related]
2. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
Jordan JH; Jäger E; Sperr WR; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P
Eur J Clin Invest; 2003 Jul; 33(7):611-8. PubMed ID: 12814399
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
Horny HP; Sotlar K; Sperr WR; Valent P
J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
[TBL] [Abstract][Full Text] [Related]
4. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
5. Hematologic aspects of systemic mastocytosis.
Parker RI
Hematol Oncol Clin North Am; 2000 Jun; 14(3):557-68. PubMed ID: 10909040
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
Sperr WR; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Feb; 127(2):140-2. PubMed ID: 11919425
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of systemic mastocytosis in Denmark.
Cohen SS; Skovbo S; Vestergaard H; Kristensen T; Møller M; Bindslev-Jensen C; Fryzek JP; Broesby-Olsen S
Br J Haematol; 2014 Aug; 166(4):521-8. PubMed ID: 24761987
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis in the elderly.
Butterfield JH; Weiler CR
Am J Hematol; 2013 May; 88(5):406-8. PubMed ID: 23436294
[TBL] [Abstract][Full Text] [Related]
10. [Systemic mastocytosis and malignant mastocytosis].
Lortholary O; Casassus P; Laroche L; Lortholary P; Diebold J
Presse Med; 1990 Jan; 19(3):125-8. PubMed ID: 2137589
[TBL] [Abstract][Full Text] [Related]
11. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
[TBL] [Abstract][Full Text] [Related]
12. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
13. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
Tefferi A; Abdelmagid M; Al-Kali A; Patnaik M; Hogan WJ; Begna K; Gangat N; Orazi A; Chen D; Reichard KK; Pardanani A
Am J Hematol; 2024 Jan; 99(1):21-27. PubMed ID: 37772442
[TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
15. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
16. Portal hypertension and ascites in systemic mastocytosis.
Narayanan MN; Liu Yin JA; Azzawi S; Warnes TW; Turck WP
Postgrad Med J; 1989 Jun; 65(764):394-6. PubMed ID: 2608581
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Sperr WR; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508
[TBL] [Abstract][Full Text] [Related]
18. Atypical myeloproliferative disorders: diagnosis and management.
Tefferi A; Elliott MA; Pardanani A
Mayo Clin Proc; 2006 Apr; 81(4):553-63. PubMed ID: 16610578
[TBL] [Abstract][Full Text] [Related]
19. Atypical myeloproliferative disorders in adults.
Zachée P
Transfus Apher Sci; 2011 Apr; 44(2):211-21. PubMed ID: 21402312
[TBL] [Abstract][Full Text] [Related]
20. [Systemic mastocytosis and malignant hemopathies. Review of the literature apropos of a case].
Maigre M; Guerzider P; Harousseau JL
Rev Med Interne; 1991; 12(5):343-9. PubMed ID: 1771313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
